Literature DB >> 26751140

Severe Epidermal Nerve Fiber Loss in Diabetic Neuropathy Is Not Reversed by Long-Term Normoglycemia After Simultaneous Pancreas and Kidney Transplantation.

T Havrdova1, P Boucek1, F Saudek1, L Voska1, A Lodererova1, N Üçeyler2, H Vondrova3, J Skibova1, K Lipar1, C Sommer2.   

Abstract

Whether nerve fiber loss, a prominent feature of advanced diabetic neuropathy, can be reversed by reestablishment of normal glucose control remains questionable. We present 8-year follow-up data on epidermal nerve fiber (ENF) density and neurological function in patients with type 1 diabetes after simultaneous pancreas and kidney transplantation (SPK) with long-term normoglycemia. Distal thigh skin biopsies with ENF counts, vibration perception thresholds (VPTs), autonomic function testing (AFT) and electrophysiological examinations were performed at time of SPK and 2.5 and 8 years after SPK in 12 patients with type 1 diabetes. In comparison to controls, baseline ENF density, VPT and AFT results of patients indicated severe neuropathy. At follow-up, all SPK recipients were insulin independent with excellent glycemic control and kidney graft function; however, the severe ENF depletion present at baseline had not improved, with total ENF absence in 11 patients at 8-year follow-up. Similarly, no amelioration occurred in the VPT and AFT results. Numerical improvement was seen in some electrophysiological parameters; however, statistical significance was achieved only in median motor nerve conduction velocity. ENF loss and functional deficits in advanced diabetic peripheral neuropathy are rarely reversible, even by long-term normoglycemia, which underscores the importance of neuropathy prevention by early optimal glycemic control. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; diabetes: secondary complications; diabetes: type 1; endocrinology/diabetology; neurology; pancreas/simultaneous pancreas-kidney transplantation

Mesh:

Year:  2016        PMID: 26751140     DOI: 10.1111/ajt.13715

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

Review 1.  Impaired Axonal Regeneration in Diabetes. Perspective on the Underlying Mechanism from In Vivo and In Vitro Experimental Studies.

Authors:  Kazunori Sango; Hiroki Mizukami; Hidenori Horie; Soroku Yagihashi
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-01       Impact factor: 5.555

2.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.

Authors:  Georgios Ponirakis; Muhammad A Abdul-Ghani; Amin Jayyousi; Hamad Almuhannadi; Ioannis N Petropoulos; Adnan Khan; Hoda Gad; Osama Migahid; Ayman Megahed; Ralph DeFronzo; Ziyad Mahfoud; Mona Hassan; Hanadi Al Hamad; Marwan Ramadan; Uazman Alam; Rayaz A Malik
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06

3.  Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation.

Authors:  Shazli Azmi; Maria Jeziorska; Maryam Ferdousi; Ioannis N Petropoulos; Georgios Ponirakis; Andrew Marshall; Uazman Alam; Omar Asghar; Andrew Atkinson; Wendy Jones; Andrew J M Boulton; Michael Brines; Titus Augustine; Rayaz A Malik
Journal:  Diabetologia       Date:  2019-06-07       Impact factor: 10.122

4.  Effect of diabetes type on long-term outcome of epidermal axon regeneration.

Authors:  Mohammad Khoshnoodi; Shaun Truelove; Michael Polydefkis
Journal:  Ann Clin Transl Neurol       Date:  2019-09-27       Impact factor: 4.511

5.  Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients.

Authors:  Lars B Dahlin; Targ Elgzyri; Magnus Löndahl; Linnéa Ekman; Eero Lindholm
Journal:  Acta Diabetol       Date:  2019-11-08       Impact factor: 4.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.